Direct-to-biology high-throughput optimization enables rapid hit-to-lead discovery of potent CDK2 inhibitors

European Journal of Medicinal Chemistry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles